abstract |
This invention relates to compounds of the formula n nwherein one of R 6 , R 7 or R 8 isn n nand all enantiomers and pharmaceutically acceptable salts and/or esters thereof as well as pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists. |